Alaa El-Hussuna1, Igors Iesalnieks2, Nir Horesh3, Sabah Hadi4, Yael Dreznik3, Oded Zmora3. 1. Ålborg University Hospital, Åalborg, Denmark. alaanewemail@gmail.com. 2. Städtisches Klinikum München Bogenhausen, Munich, Germany. 3. Sheba Medical Center, Tel Hashomer, Israel. 4. Bispiberg Hospital, 2400, Copenhagen, Denmark.
Abstract
BACKGROUND: The timing of surgical intervention in Crohn's disease (CD) may depend on pre-operative optimization (PO) which includes different interventions to decrease the risk for unfavourable post-operative outcome. The objective of this study was to investigate the effect of multi-model PO on the post-operative outcome in CD. METHOD: This is a multicentre retrospective cohort study. The primary outcome was 30-day post-operative complications. Secondary outcomes were intra-abdominal septic complications, surgical site infection (SSI), re-operation, length of post-operative stay in a hospital and re-admission. PO included nutritional support, discontinuation of medications, pre-operative antibiotic course and thrombosis prophylaxis. RESULTS: Two hundred and thirty-seven CD elective bowel resections were included. Mean age was 39.9 years SD 14.25, 144 (60.8 %) were female and 129 (54.4 %) had one or more types of medical treatment pre-operatively. Seventy-seven patients (32.5 %) optimized by at least nutritional support or change in pre-operative medications. PO patients were more likely to have penetrating disease phenotype (p = 0.034), lower albumin (p = 0.015) and haemoglobin (p = 0.021) compared to the non-optimized. Multivariate analyses showed that treatment with anti-TNF alpha agents OR 2.058 CI [1.043-4.4.064] and low haemoglobin OR 0.741 CI [0.572-0.0.961] increased the risk of overall post-operative complications. Co-morbidity increased the risk of SSI OR 2.567 CI [1.182-5.576] while low haemoglobin was a risk factor for re-admission OR 0.613 CI [0.405-0.926]. Low pre-operative albumin correlated with longer stay in hospital. CONCLUSIONS: PO did not change post-operative outcome most likely due to selection bias. Anti-TNF alpha agents, low haemoglobin, low albumin and co-morbidity were associated with unfavourable outcome.
BACKGROUND: The timing of surgical intervention in Crohn's disease (CD) may depend on pre-operative optimization (PO) which includes different interventions to decrease the risk for unfavourable post-operative outcome. The objective of this study was to investigate the effect of multi-model PO on the post-operative outcome in CD. METHOD: This is a multicentre retrospective cohort study. The primary outcome was 30-day post-operative complications. Secondary outcomes were intra-abdominal septic complications, surgical site infection (SSI), re-operation, length of post-operative stay in a hospital and re-admission. PO included nutritional support, discontinuation of medications, pre-operative antibiotic course and thrombosis prophylaxis. RESULTS: Two hundred and thirty-seven CD elective bowel resections were included. Mean age was 39.9 years SD 14.25, 144 (60.8 %) were female and 129 (54.4 %) had one or more types of medical treatment pre-operatively. Seventy-seven patients (32.5 %) optimized by at least nutritional support or change in pre-operative medications. PO patients were more likely to have penetrating disease phenotype (p = 0.034), lower albumin (p = 0.015) and haemoglobin (p = 0.021) compared to the non-optimized. Multivariate analyses showed that treatment with anti-TNF alpha agents OR 2.058 CI [1.043-4.4.064] and low haemoglobin OR 0.741 CI [0.572-0.0.961] increased the risk of overall post-operative complications. Co-morbidity increased the risk of SSI OR 2.567 CI [1.182-5.576] while low haemoglobin was a risk factor for re-admission OR 0.613 CI [0.405-0.926]. Low pre-operative albumin correlated with longer stay in hospital. CONCLUSIONS: PO did not change post-operative outcome most likely due to selection bias. Anti-TNF alpha agents, low haemoglobin, low albumin and co-morbidity were associated with unfavourable outcome.
Authors: P Zerbib; D Koriche; S Truant; A F Bouras; G Vernier-Massouille; D Seguy; F R Pruvot; A Cortot; J F Colombel Journal: Aliment Pharmacol Ther Date: 2010-05-22 Impact factor: 8.171
Authors: René Müller-Wille; Igors Iesalnieks; Christian Dornia; Claudia Ott; Ernst Michael Jung; Chris Friedrich; Gabriela Schill; Patrick Hoffstetter; Niels Zorger; Andreas G Schreyer Journal: Int J Colorectal Dis Date: 2011-02-01 Impact factor: 2.571
Authors: Isabelle Cleynen; Gabrielle Boucher; Luke Jostins; L Philip Schumm; Sebastian Zeissig; Tariq Ahmad; Vibeke Andersen; Jane M Andrews; Vito Annese; Stephan Brand; Steven R Brant; Judy H Cho; Mark J Daly; Marla Dubinsky; Richard H Duerr; Lynnette R Ferguson; Andre Franke; Richard B Gearry; Philippe Goyette; Hakon Hakonarson; Jonas Halfvarson; Johannes R Hov; Hailang Huang; Nicholas A Kennedy; Limas Kupcinskas; Ian C Lawrance; James C Lee; Jack Satsangi; Stephan Schreiber; Emilie Théâtre; Andrea E van der Meulen-de Jong; Rinse K Weersma; David C Wilson; Miles Parkes; Severine Vermeire; John D Rioux; John Mansfield; Mark S Silverberg; Graham Radford-Smith; Dermot P B McGovern; Jeffrey C Barrett; Charlie W Lees Journal: Lancet Date: 2015-10-18 Impact factor: 202.731
Authors: Christian Galata; Christel Weiss; Julia Hardt; Steffen Seyfried; Stefan Post; Peter Kienle; Karoline Horisberger Journal: Int J Colorectal Dis Date: 2018-05-07 Impact factor: 2.571
Authors: A El-Hussuna; M L M Karer; N N Uldall Nielsen; A Mujukian; P R Fleshner; I Iesalnieks; N Horesh; U Kopylov; H Jacoby; H M Al-Qaisi; F Colombo; G M Sampietro; M V Marino; M Ellebæk; C Steenholdt; N Sørensen; V Celentano; N Ladwa; J Warusavitarne; G Pellino; A Zeb; F Di Candido; L Hurtado-Pardo; M Frasson; L Kunovsky; A Yalcinkaya; O C Tatar; S Alonso; M Pera; A G Granero; C A Rodríguez; A Minaya; A Spinelli; N Qvist Journal: BJS Open Date: 2021-09-06
Authors: Susanna Meade; Kamal V Patel; Raphael P Luber; Dearbhaile O'Hanlon; Andra Caracostea; Polychronis Pavlidis; Sailish Honap; Cheran Anandarajah; Nyree Griffin; Sebastian Zeki; Shuvra Ray; Joel Mawdsley; Mark A Samaan; Simon H Anderson; Amir Darakhshan; Katie Adams; Andrew Williams; Jeremy D Sanderson; Miranda Lomer; Peter M Irving Journal: Aliment Pharmacol Ther Date: 2022-06-20 Impact factor: 9.524